# Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection

> **NCT06953271** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Women and Infants Hospital of Rhode Island** · enrollment: 164 (estimated)

## Conditions studied

- Overactive Bladder (OAB)
- Urinary Tract Infection (Diagnosis)

## Interventions

- **DRUG:** Methenamine Hippurate
- **DRUG:** Typically prescribed oral antibiotic prophylaxis

## Key facts

- **NCT ID:** NCT06953271
- **Lead sponsor:** Women and Infants Hospital of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2026-05-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953271, "Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06953271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*